Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jul 17 01:04PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-1.00 Insider Own42.03% Shs Outstand28.56M Perf Week-10.51%
Market Cap35.33M Forward P/E- EPS next Y-0.65 Insider Trans0.00% Shs Float16.59M Perf Month2.92%
Income-19.39M PEG- EPS next Q-0.15 Inst Own10.74% Short Float0.18% Perf Quarter1.23%
Sales1.13M P/S31.27 EPS this Y44.72% Inst Trans0.37% Short Ratio0.97 Perf Half Y-26.49%
Book/sh0.02 P/B57.93 EPS next Y5.15% ROA-344.43% Short Interest0.03M Perf Year-19.34%
Cash/sh0.10 P/C11.78 EPS next 5Y- ROE-22663.91% 52W Range0.89 - 2.12 Perf YTD-22.33%
Dividend Est.- P/FCF- EPS past 5Y-88.22% ROI-3090.46% 52W High-41.86% Beta-0.33
Dividend TTM- Quick Ratio0.97 Sales past 5Y5.96% Gross Margin-201.93% 52W Low38.39% ATR (14)0.09
Dividend Ex-Date- Current Ratio1.01 EPS Y/Y TTM48.69% Oper. Margin-1789.01% RSI (14)46.77 Volatility8.31% 7.25%
Employees8 Debt/Eq1.10 Sales Y/Y TTM-15.51% Profit Margin-1721.64% Recom1.00 Target Price2.80
Option/ShortNo / Yes LT Debt/Eq0.03 EPS Q/Q66.62% Payout- Rel Volume0.40 Prev Close1.22
Sales Surprise-46.64% EPS Surprise22.40% Sales Q/Q32.83% EarningsMay 16 BMO Avg Volume30.08K Price1.24
SMA20-1.12% SMA50-5.61% SMA200-12.19% Trades Volume6,910 Change1.23%
Jun-25-24 09:25AM
Jun-14-24 04:01PM
May-30-24 09:00AM
May-16-24 08:05AM
06:53AM Loading…
Mar-19-24 06:53AM
Mar-18-24 09:05AM
Mar-14-24 09:34AM
Mar-13-24 05:04PM
Jan-29-24 09:15AM
Dec-27-23 04:15PM
Dec-18-23 09:15AM
Dec-14-23 04:01PM
Nov-21-23 08:05AM
Nov-15-23 08:05AM
04:01PM Loading…
Oct-30-23 04:01PM
Oct-23-23 08:05AM
Oct-05-23 08:05AM
Sep-21-23 09:35AM
Aug-15-23 08:05AM
Aug-02-23 08:16AM
Jun-29-23 01:32PM
Jun-13-23 04:01PM
Jun-12-23 08:05AM
Jun-05-23 08:05AM
May-15-23 08:05AM
May-02-23 08:12AM
Apr-21-23 08:05AM
Mar-20-23 08:05AM
01:00PM Loading…
Jan-11-23 01:00PM
Jan-10-23 08:05AM
Jan-09-23 08:05AM
Jan-04-23 04:05PM
Dec-30-22 08:00AM
Nov-11-22 08:05AM
Oct-18-22 08:05AM
Oct-04-22 08:05AM
Sep-28-22 02:02PM
Sep-07-22 08:05AM
Aug-16-22 08:05AM
Aug-08-22 08:05AM
Jul-21-22 08:05AM
Jul-12-22 07:30AM
Jul-11-22 08:05AM
Jun-21-22 08:05AM
May-18-22 08:00AM
May-12-22 04:05PM
May-09-22 08:05AM
Mar-29-22 08:35AM
Mar-24-22 08:05AM
Mar-23-22 08:25AM
Mar-14-22 08:05AM
Mar-10-22 08:05AM
Feb-08-22 08:05AM
Feb-03-22 08:05AM
Jan-20-22 08:05AM
Jan-12-22 10:35AM
Dec-16-21 06:16AM
Dec-09-21 08:05AM
Dec-06-21 08:05AM
Nov-16-21 08:28PM
Nov-15-21 04:20PM
Nov-10-21 08:05AM
Nov-04-21 02:30PM
Nov-02-21 08:05AM
Oct-19-21 09:15AM
Oct-18-21 08:05AM
Oct-06-21 08:05AM
Sep-27-21 08:05AM
Sep-15-21 08:05AM
Sep-08-21 08:05AM
Aug-17-21 08:05AM
Jul-30-21 08:05AM
Jul-27-21 08:05AM
Jun-21-21 08:05AM
Jun-19-21 03:37AM
Jun-17-21 08:05AM
Jun-15-21 08:05AM
Jun-14-21 08:05AM
Jun-12-21 04:06AM
Jun-09-21 08:05AM
May-20-21 09:05AM
May-17-21 09:05AM
May-11-21 09:05AM
Apr-27-21 09:05AM
Apr-20-21 09:25AM
Mar-25-21 08:35AM
Mar-15-21 08:05AM
Mar-12-21 08:05AM
Mar-10-21 08:35AM
Mar-09-21 09:05AM
Mar-04-21 09:10AM
Mar-01-21 09:05AM
Feb-22-21 09:00AM
Feb-09-21 08:05AM
Cyclo Therapeutics, Inc. engages in the development of cyclodextrin-based biopharmaceuticals for the treatment of disease. Its product pipeline include Trappsol Cyclo, which treats Neimann-Pick Type C disease and Alzheimer's disease. The company was founded by Charles E. Rick Strattan on August 9, 1990 and is headquartered in Gainesville, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Rafael Holdings, Inc.10% OwnerAug 01 '23Buy1.254,000,0005,000,0006,514,970Aug 02 04:43 PM